Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W M Flanagan

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Cancer Metastasis Reviews|October 14, 1998
Antisense comes of ageW M Flanagan
The Journal of Biological Chemistry|January 5, 1992
In vitro transcription faithfully reflecting T-cell activation requirementsW M Flanagan, G R Crabtree
Molecular Medicine Today|January 1, 1997
Antisense technology and prospects for therapy of viral infections and cancerR W Wagner, W M Flanagan
Annals of the New York Academy of Sciences|November 30, 1993
Rapamycin inhibits p34cdc2 expression and arrests T lymphocyte proliferation at the G1/S transitionW M Flanagan, G R Crabtree
Molecular and Cellular Biochemistry|July 1, 1997
Potent and selective gene inhibition using antisense oligodeoxynucleotidesW M Flanagan, R W Wagner
Virus Genes|November 1, 1987
A bi-functional reporter plasmid for the simultaneous transient expression assay of two herpes simplex virus promotersW M Flanagan, E K Wagner
Nucleic Acids Research|August 1, 1996
Effects of oligonucleotide length, mismatches and mRNA levels on C-5 propyne-modified antisense potencyW M Flanagan, A Kothavale, R W Wagner
Nature Biotechnology|September 1, 1996
Elucidation of gene function using C-5 propyne antisense oligonucleotidesW M Flanagan, L L Su, R W Wagner
Science (New York, N.Y.)|May 10, 1996
Requirement of p27Kip1 for restriction point control of the fibroblast cell cycleS Coats, W M Flanagan, J Nourse, et al.
Chemical Immunology|January 1, 1992
Regulation of the interleukin-2 geneJ S Riegel, B Corthesy, W M Flanagan, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Cancer Metastasis Reviews|October 14, 1998
Antisense comes of ageW M Flanagan
The Journal of Biological Chemistry|January 5, 1992
In vitro transcription faithfully reflecting T-cell activation requirementsW M Flanagan, G R Crabtree
Molecular Medicine Today|January 1, 1997
Antisense technology and prospects for therapy of viral infections and cancerR W Wagner, W M Flanagan
Annals of the New York Academy of Sciences|November 30, 1993
Rapamycin inhibits p34cdc2 expression and arrests T lymphocyte proliferation at the G1/S transitionW M Flanagan, G R Crabtree
Molecular and Cellular Biochemistry|July 1, 1997
Potent and selective gene inhibition using antisense oligodeoxynucleotidesW M Flanagan, R W Wagner
Virus Genes|November 1, 1987
A bi-functional reporter plasmid for the simultaneous transient expression assay of two herpes simplex virus promotersW M Flanagan, E K Wagner
Nucleic Acids Research|August 1, 1996
Effects of oligonucleotide length, mismatches and mRNA levels on C-5 propyne-modified antisense potencyW M Flanagan, A Kothavale, R W Wagner
Nature Biotechnology|September 1, 1996
Elucidation of gene function using C-5 propyne antisense oligonucleotidesW M Flanagan, L L Su, R W Wagner
Science (New York, N.Y.)|May 10, 1996
Requirement of p27Kip1 for restriction point control of the fibroblast cell cycleS Coats, W M Flanagan, J Nourse, et al.
Chemical Immunology|January 1, 1992
Regulation of the interleukin-2 geneJ S Riegel, B Corthesy, W M Flanagan, et al.
Pageof 4